In a significant leap toward futuristic tech, the U.S. Department of Defense (DoD) is funding Sense Neuro Diagnostics to conduct clinical trials for the NeuroHawk device, a revolutionary tool for battlefield brain injury detection. Starting in June 2025, these trials will test NeuroHawk’s ability to diagnose traumatic brain injury (TBI) and detect brain hemorrhages within seconds—directly on the battlefield.
Awarded a $2 million contract by the DoD’s Congressionally Directed Medical Research Programs (CDMRP) through the Traumatic Brain Injury and Psychological Health Research Program (TBI PHRP), Sense Neuro Diagnostics will lead this project. NeuroHawk’s rapid detection capabilities could redefine TBI care in combat, using low-power radio frequency (RF) tech to swiftly detect brain injuries when time is critical.
NeuroHawk: High-Tech Headgear to Save Lives
NeuroHawk is not just another device but could redefine how medics handle TBI on the battlefield. Sense Neuro Diagnostics has positioned the device as a solution for battlefield brain injury detection, helping first responders make critical decisions faster and reducing the chances of secondary injury.
While military applications are top priority, NeuroHawk also has potential in hospital and EMS settings, where its rapid TBI and stroke diagnosis could transform emergency care. Sense Neuro Diagnostics aims to expand the device’s impact from the front lines to civilian healthcare systems, showing how tech developed for combat could improve treatment options everywhere.
Changing the Standard of TBI Diagnosis
Traumatic brain injury has impacted over 420,000 U.S. service members in the last two decades, and with modern combat risks increasing, the need for efficient battlefield brain injury detection is rising. NeuroHawk’s capability for quick, objective assessment can address this gap, making it a critical development for military and civilian use.
Geoff Klass, CEO of Sense Neuro Diagnostics, shared his excitement about the trial, stating, “This contract allows us to advance life-saving technology for military personnel and civilians alike.” source
With FDA clearance expected in early 2025 and a commercial launch planned for mid-2025, NeuroHawk could soon be saving lives beyond the battlefield. source
The Future of Battlefield Brain Injury Detection
Thanks to continued support from the military, NeuroHawk is on track to become a standard in TBI diagnosis, both in combat and emergency response. For readers interested in other tech innovations making waves in modern warfare, check out our article on Zombie Missile Test Shows US Advancing in Defense Technology.